Literature DB >> 29261232

A Mouse Model of West Nile Virus Infection.

Jessica B Graham1, Jessica L Swarts1, Jennifer M Lund1,2.   

Abstract

The use of a mouse model to study the breadth of symptoms and disease severity seen in human West Nile virus (WNV) infection can provide insight into the kinetics of the immune response and the specific pathways responsible for control of WNV infection and viral clearance. Here, we provide protocols for performing WNV infection of mice, as well as complete immunophenotyping analysis of the cellular immune response to infection in both the periphery and the central nervous system in a mouse model of WNV infection. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  West Nile virus; clinical disease; immunophenotyping

Mesh：

Year:  2017        PMID： 29261232      PMCID： PMC5777180          DOI： 10.1002/cpmo.33

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN： 2161-2617


  29 in total

Review 1.  A practical guide to understanding Kaplan-Meier curves.

Authors:  Jason T Rich; J Gail Neely; Randal C Paniello; Courtney C J Voelker; Brian Nussenbaum; Eric W Wang
Journal:  Otolaryngol Head Neck Surg       Date:  2010-09       Impact factor: 3.497

Review 2.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

3.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection.

Authors:  John S Errett; Mehul S Suthar; Aimee McMillan; Michael S Diamond; Michael Gale
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

5.  Clinical spectrum of muscle weakness in human West Nile virus infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic; Risa M Webb; Sally A Slavinski; Jonathan Fratkin
Journal:  Muscle Nerve       Date:  2003-09       Impact factor: 3.217

Review 6.  The long-term outcomes of human West Nile virus infection.

Authors:  James J Sejvar
Journal:  Clin Infect Dis       Date:  2007-05-02       Impact factor: 9.079

7.  The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics.

Authors:  Adam Roberts; Fernando Pardo-Manuel de Villena; Wei Wang; Leonard McMillan; David W Threadgill
Journal:  Mamm Genome       Date:  2007-08-03       Impact factor: 2.957

8.  Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.

Authors:  Jessica B Graham; Sunil Thomas; Jessica Swarts; Aimee A McMillan; Martin T Ferris; Mehul S Suthar; Piper M Treuting; Renee Ireton; Michael Gale; Jennifer M Lund
Journal:  MBio       Date:  2015-05-05       Impact factor: 7.867

9.  Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus.

Authors:  Mukesh Kumar; Kelsey Roe; Pratibha V Nerurkar; Beverly Orillo; Karen S Thompson; Saguna Verma; Vivek R Nerurkar
Journal:  J Neuroinflammation       Date:  2014-04-21       Impact factor: 8.322

10.  Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.

Authors:  Stephane Daffis; Mehul S Suthar; Kristy J Szretter; Michael Gale; Michael S Diamond
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823
View more
  5 in total

1.  STING is required for host defense against neuropathological West Nile virus infection.

Authors:  Kathryn McGuckin Wuertz; Piper M Treuting; Emily A Hemann; Katharina Esser-Nobis; Annelise G Snyder; Jessica B Graham; Brian P Daniels; Courtney Wilkins; Jessica M Snyder; Kathleen M Voss; Andrew Oberst; Jennifer Lund; Michael Gale
Journal:  PLoS Pathog       Date:  2019-08-15       Impact factor: 6.823

Review 2.  Molecular Determinants of West Nile Virus Virulence and Pathogenesis in Vertebrate and Invertebrate Hosts.

Authors:  Lise Fiacre; Nonito Pagès; Emmanuel Albina; Jennifer Richardson; Sylvie Lecollinet; Gaëlle Gonzalez
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

3.  Correlation of Regulatory T Cell Numbers with Disease Tolerance upon Virus Infection.

Authors:  Jessica B Graham; Jessica L Swarts; Kristina R Edwards; Kathleen M Voss; Richard Green; Sophia Jeng; Darla R Miller; Michael A Mooney; Shannon K McWeeney; Martin T Ferris; Fernando Pardo-Manuel de Villena; Michael Gale; Jennifer M Lund
Journal:  Immunohorizons       Date:  2021-04-23

4.  Immune Correlates of Protection From West Nile Virus Neuroinvasion and Disease.

Authors:  Jessica B Graham; Jessica L Swarts; Sunil Thomas; Kathleen M Voss; Aimee Sekine; Richard Green; Renee C Ireton; Michael Gale; Jennifer M Lund
Journal:  J Infect Dis       Date:  2019-03-15       Impact factor: 7.759

5.  Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.

Authors:  Jessica B Graham; Jessica L Swarts; Vineet D Menachery; Lisa E Gralinski; Alexandra Schäfer; Kenneth S Plante; Clayton R Morrison; Kathleen M Voss; Richard Green; Gabrielle Choonoo; Sophia Jeng; Darla R Miller; Michael A Mooney; Shannon K McWeeney; Martin T Ferris; Fernando Pardo-Manuel de Villena; Michael Gale; Mark T Heise; Ralph S Baric; Jennifer M Lund
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.